Overview
HCA market data
Price History
HCA price chart
Valuation & Profitability
- P/E (TTM)
- 12.38 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $28.33 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.12 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 82.9% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $330.00 – $556.52 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $84.1K · P/B 97.29 · P/S 1.10.
Company news
S&P 500 Rises As Oil Sinks On Iran Talk Hopes: Stock Market TodayBenzinga · Jul 24, 2026, 5:59 PM
This "BOGO Strategy" Can Get You 3 Stocks at a DiscountBenzinga · Jul 24, 2026, 3:55 PM
HCA Healthcare Surpasses Q2 Estimates With Strong Admissions GrowthBenzinga · Jul 24, 2026, 3:33 PM
HCA Healthcare Exec Says Long-Term Patient Volume Growth Expected At 2%-3%, Supported By Market Demographics And Population Growth; Original Assumption Around Declining Utilization For Patients That Become Uninsured Due To The Loss Of Insurance Coverage Did Not MaterializeBenzinga · Jul 24, 2026, 2:30 PM
HCA Healthcare shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Jul 24, 2026, 2:08 PM
8-K filing — HCA Healthcare, Inc. (HCA)SEC EDGAR · Jul 24, 2026, 11:45 AM
HCA Healthcare Affirms FY2026 GAAP EPS Guidance of $28.70-$30.50 vs $29.70 Est; Affirms FY2026 Sales Guidance of $77.000B-$79.500B vs $78.457B EstBenzinga · Jul 24, 2026, 11:31 AM
HCA Healthcare Q2 Adj. EPS $7.59 Beats $7.02 Estimate, Sales $20.230B Beat $19.400B EstimateBenzinga · Jul 24, 2026, 11:30 AM
Earnings Scheduled For July 24, 2026Benzinga · Jul 24, 2026, 11:11 AM
Nasdaq Tumbles Over 2% Amid Higher Oil Prices: Investor Sentiment Weakens, Greed Index Remains In ‘Fear’ ZoneBenzinga · Jul 24, 2026, 6:47 AM